Condition
Axial Spondylarthritis (axSpA) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Axial Spondylarthritis (axSpA) clinical trials that are recruiting, at sites in 4 countries (most in United Kingdom (1), Germany (1), Belgium (1)). By phase: Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Axial Spondylarthritis (axSpA) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| FAPI‑74 PET/CT versus FDG PET/CT for inflammation in FUO, IgG4‑RD, and axial spondyloarthritis | Phase 2/3 | Leuven | Recruiting | Apr 17, 2026 |
| Comparing five advanced treatments for axial spondyloarthritis and psoriatic arthritis | — | Bath, Somerset | Recruiting | Sep 10, 2025 |
| Personalized lab test to predict the best treatment for rheumatic diseases | — | Bonn, North Rhine-Westphalia | Recruiting | Sep 2, 2025 |
| Early standardized global review for people with axial spondyloarthritis | — | Besançon and 20 other locations | Recruiting | Aug 26, 2025 |
All recruiting trials (4)
-
FAPI‑74 PET/CT versus FDG PET/CT for inflammation in FUO, IgG4‑RD, and axial spondyloarthritis
This project will test whether [18F]-AlF-FAPI-74 PET/CT finds inflammation more accurately than standard [18F]-FDG PET/CT in people with fever of unknown origin, IgG4‑related disease, or axial spondyloarthritis.
-
Comparing five advanced treatments for axial spondyloarthritis and psoriatic arthritis
This project will see how well bimekizumab, risankizumab, guselkumab, upadacitinib, or a TNF inhibitor work for adults with axSpA or PsA who have just started one of these medicines, using medical records and patient surveys.
-
Personalized lab test to predict the best treatment for rheumatic diseases
This project tests a lab-based cell assay to see if it can predict which DMARD will work best for adults with autoimmune rheumatic diseases such as RA, PsA, axSpA, and GCA.
-
Early standardized global review for people with axial spondyloarthritis
This study will test whether giving a standardized global review (including disease assessments and education) soon after diagnosis helps adults with recent axial spondyloarthritis improve their knowledge over 12 months.
Related topics
Quick answers
How many Axial Spondylarthritis (axSpA) clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United Kingdom (1 trial), Germany (1 trial), Belgium (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.